CN1058163C - Yigan Kangyangsan powder for curing hepatitis B - Google Patents
Yigan Kangyangsan powder for curing hepatitis B Download PDFInfo
- Publication number
- CN1058163C CN1058163C CN95105621A CN95105621A CN1058163C CN 1058163 C CN1058163 C CN 1058163C CN 95105621 A CN95105621 A CN 95105621A CN 95105621 A CN95105621 A CN 95105621A CN 1058163 C CN1058163 C CN 1058163C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- powder
- yigan
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to Yigan Kangyang powder for treating hepatitis B by using Chinese medicines, which overcomes the defects of the existing treating methods. The Yigan Kangyang powder treats the hepatic diseases according to the differentiation of symptoms and signs for combined regulation, and has specially good effect on treating hepatitis B, hepatitis C and early liver cirrhosis. One of the prescriptions provided by the present invention contains 15 parts of red sage root, 10 parts of angelica root, 20 parts of red peony root, 15 parts of scorch-fried ovate atractylodes root, 10 parts of poria coco, 15 parts of scorch-fried crataegus fruit, 10 parts of aurantii, 1 part of curcuma root, 10 parts of rhizoma corydalis, 10 parts of fructus toosendan, 20 parts of turtle shell, 15 parts of pangolin scale, 10 parts of notoginseng and 6 parts of licorice. The Yigan Kangyang powder can be made into pellets, medicinal powder, oral liquid, etc. according to actual demands.
Description
The present invention is a kind of Chinese medicine preparation, particularly a kind of medicine that hepatopathy is had the treatment hepatitis B of special curative effect.
Liver's pathological changes such as hepatitis B, liver cirrhosis, cirrhotic ascites are one of common clinicals, also are global problems.Though the report of various treatment hepatopathy is arranged at present, all exist curative effect not high, disadvantages such as treatment cycle length.
Of the present invention is deficiency at prior art, provides a kind of to hepatitis B, hepatitis C, early stage liver cirrhosis curative effect height, the Yigan Kangyangsan powder for curing hepatitis B that treatment cycle is short.
The present invention is directed to the pathogeny of hepatopathy, dialectical executing controlled, comprehensive adjustment, and it consists of (weight ratio) to the treating hepatitis B medicine that provides according to different situations:
15 parts of Radix Pseudostellariaes, 10 parts of Radix Ophiopogonis, 15 parts of Fructus Lycii, 15 parts of Rhizoma Polygonatis, 10 parts of Radix Angelicae Sinensis, 10 parts of the Radix Paeoniae Albas, 10 parts in Poria, 15 parts of Herba Artemisiae Scopariaes, 15 parts of Flos Loniceraes, 6 parts of Fructus Forsythiaes, 10 parts of Radix Isatidiss, 15 parts of Radix Dipsaci, 10 parts of Fructus Schisandrae Chinensis, 10 parts of Rhizoma Cyperis, 6 parts of Radix Bupleuri, 6 parts of Radix Notoginseng, 15 parts of Carapax Trionycis, 15 parts of Squama Maniss, 6 parts in Radix Glycyrrhizae.
Advantage of the present invention is that dialectical executing controlled, and comprehensive adjustment is effective in cure to the hepatopathy that different reasons cause, and can have strong liver effect through nearly 108 routine clinical verifications, and effective percentage reaches more than 85%.
Embodiment 1: Radix Pseudostellariae 15g, Radix Ophiopogonis 10g, Fructus Lycii 15g, Rhizoma Polygonati 15g, Radix Angelicae Sinensis 10g, Radix Paeoniae Alba 10g, Poria 10g, Herba Artemisiae Scopariae 15g, Flos Lonicerae 15g, Fructus Forsythiae 6g, Radix Isatidis 10g, Radix Dipsaci 15g, Fructus Schisandrae Chinensis 10g, Rhizoma Cyperi 10g, Radix Bupleuri 6g, Radix Notoginseng 6g, Carapax Trionycis 15g, Squama Manis 15g, Radix Glycyrrhizae 6g.Make pill, treatment hepatic and renal YIN deficiency disease and stagnation of liver-QI with deficiency of the spleen produce disease of the liver.
Claims (1)
1, a kind of medicine for the treatment of hepatitis B is characterized in that it is to be made by the raw material of following weight ratio:
15 parts of Radix Pseudostellariaes, 15 parts of Radix Ophiopogonis, 15 parts of Fructus Lycii, 15 parts of Rhizoma Polygonatis, 10 parts of Radix Angelicae Sinensis, 15 parts of the Radix Paeoniae Albas, 10 parts in Poria, 15 parts of Herba Artemisiae Scopariaes, 15 parts of Flos Loniceraes, 6 parts of Fructus Forsythiaes, 10 parts of Radix Isatidiss, 15 parts of Radix Dipsaci, 10 parts of Fructus Schisandrae Chinensis, 10 parts of Rhizoma Cyperis, 6 parts of Radix Bupleuri, 6 parts of Radix Notoginseng, 15 parts of Carapax Trionycis, 15 parts of Squama Maniss, 6 parts in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95105621A CN1058163C (en) | 1995-06-02 | 1995-06-02 | Yigan Kangyangsan powder for curing hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95105621A CN1058163C (en) | 1995-06-02 | 1995-06-02 | Yigan Kangyangsan powder for curing hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1137383A CN1137383A (en) | 1996-12-11 |
| CN1058163C true CN1058163C (en) | 2000-11-08 |
Family
ID=5075551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95105621A Expired - Fee Related CN1058163C (en) | 1995-06-02 | 1995-06-02 | Yigan Kangyangsan powder for curing hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058163C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100356960C (en) * | 2006-07-06 | 2007-12-26 | 张砚 | Synergistic medicinal composition for treating hepatitis |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110314C (en) * | 1999-01-21 | 2003-06-04 | 赵承文 | Recovery powder for heptitis C |
| CN100342894C (en) * | 2005-08-16 | 2007-10-17 | 何慕周 | A Chinese medicine for treating liver disease |
| CN101797337B (en) * | 2010-04-15 | 2011-12-21 | 宁波市江北威曼生物科技有限公司 | Medicine containing Guadisu |
| CN103316305B (en) * | 2013-07-13 | 2015-04-01 | 华菊 | Traditional Chinese medicine composition for treating liver cirrhosis and preparation method thereof |
| CN107496736A (en) * | 2017-08-28 | 2017-12-22 | 段祖垒 | A kind of Chinese medicine powder and preparation method for treating damp-heat type chronic hepatitis B |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1086134A (en) * | 1992-10-23 | 1994-05-04 | 刘祥臬 | A kind of Chinese medicine for the treatment of hepatopathy---Chinese heparin |
| CN1098294A (en) * | 1993-07-31 | 1995-02-08 | 天津市第一医院 | Manganning medicine |
| CN1100642A (en) * | 1993-09-22 | 1995-03-29 | 李彤 | Traditional Chinese medicine prepn. for curing B-hepatitis |
-
1995
- 1995-06-02 CN CN95105621A patent/CN1058163C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1086134A (en) * | 1992-10-23 | 1994-05-04 | 刘祥臬 | A kind of Chinese medicine for the treatment of hepatopathy---Chinese heparin |
| CN1098294A (en) * | 1993-07-31 | 1995-02-08 | 天津市第一医院 | Manganning medicine |
| CN1100642A (en) * | 1993-09-22 | 1995-03-29 | 李彤 | Traditional Chinese medicine prepn. for curing B-hepatitis |
Non-Patent Citations (3)
| Title |
|---|
| 《上海中医药杂志》(2) 1984.2.29 王冠庭等，中西医结合治疗80例慢性活动性肝炎疗效观察 * |
| 《江苏中医》(9) 1989.9.30 赵学银，扶正活血汤治疗慢性肝炎12例 * |
| 《江苏中医》(9) 1989.9.30 赵学银，扶正活血汤治疗慢性肝炎12例;《上海中医药杂志》(2) 1984.2.29 王冠庭等，中西医结合治疗80例慢性活动性肝炎疗效观察 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100356960C (en) * | 2006-07-06 | 2007-12-26 | 张砚 | Synergistic medicinal composition for treating hepatitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1137383A (en) | 1996-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1124153C (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN103356961B (en) | Traditional Chinese medicinal composition for treating amenorrhoea | |
| CN1279073A (en) | Antisenility Chinese medicine | |
| CN1679913A (en) | Gynecologic rehabilitation capsules for treating gynecopathy | |
| CN101104069A (en) | Traditional Chinese medicine formula for treating liver (biliary) inflammation | |
| CN101884764A (en) | Medicament for treating chronic hepatitis splenomegaly or cirrhosis splenomegaly | |
| CN102512590B (en) | Chinese medicine for treating reversible pulpitis and preparation method thereof | |
| CN1058163C (en) | Yigan Kangyangsan powder for curing hepatitis B | |
| CN1164317C (en) | Zaizao Pill for treating woman diseases | |
| CN101579493A (en) | Donkey-hide gelatin paste of traditional Chinese medicine | |
| CN1052413C (en) | Yinhuang Ganfu powder for curing hepatitis | |
| CN101062212A (en) | Chinese medicinal herb composition for treating gastritis | |
| CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
| CN1218706C (en) | Hepatitis B treaitng pill | |
| CN1055223C (en) | Chinese medicine preparation for treatment of gastric ulcer, duodenal ulcer and gastritis | |
| CN1159037C (en) | Medicine for treating apoplexy | |
| CN101234189A (en) | Chinese medicine composition for preventing and treating cardiovascular inflammation (toxin) | |
| CN1052884C (en) | Traditional Chinese medicine Baiyuwan pill for treating vitiligo | |
| CN100335116C (en) | Medicament for treating leprous psora | |
| CN101167921A (en) | Medicinal composition for treating stomachache and preparation process thereof | |
| CN1233382C (en) | Chinese medicine 'Shentiansu' for internal organ diseases | |
| CN1413680A (en) | Chinese medicine for treating hyperosteogeny | |
| CN105998645A (en) | Traditional Chinese medicine composition for treating leukotrichia and lipsotrichia | |
| CN102423441A (en) | Double-formula medicine used for treating constipation, and preparation method thereof | |
| CN1195531C (en) | Chinese medicinal herbs prescription for treating hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |